Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeutics (Q87503251)
Jump to navigation
Jump to search
scientific article published on 12 July 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeutics |
scientific article published on 12 July 2014 |
Statements
Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeutics (English)
Beth L Thurberg
James M Murray
Anne Marie Thompson
Allison Vitsky
Michael Hawes
Wei-Lien Chuang
Joshua Pacheco
Stephen Wilson
John M McPherson
Kenneth P Karey
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference